The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01092481
Recruitment Status : Unknown
Verified May 2019 by Young Suk Park, Samsung Medical Center.
Recruitment status was:  Active, not recruiting
First Posted : March 25, 2010
Last Update Posted : May 21, 2019
Sponsor:
Information provided by (Responsible Party):
Young Suk Park, Samsung Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):